$BSVN

Haines Douglas A sold $44K of BSVN

Haines Douglas A (Reg. Pres. of West. OK & KS) sold 1,000 shares of Bank7 Corp. (BSVN) at $44.07 on 2026-05-28.

Original reporting
SEC EDGAR · Haines Douglas A
Published May 29, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:54 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BSVN
Neutral
medium confidence
Mentioned
$BSVN
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BSVNNeutralLow
01

Why it matters

The newest fact is the specific open-market sale details (1,000 shares at $44.0740) and the post-transaction holdings (16,647 shares).

02

Market read

Traders may briefly reassess sentiment around insider behavior, but the disclosure does not include guidance, financial results, or operational changes.

03

What to watch

No 10b5-1 plan is stated, but the article provides no context on prior sales, compensation timing, or whether the insider’s remaining stake is subject to other constraints.

Relevance 3/10Novelty 3/10Timing: filed 2026-05-29 after-hours/late session; reflects 2026-05-28 sale

Background

The article is a SEC Form 4 insider transaction disclosure for Bank7 Corp. (BSVN).

Company-level read

Ticker impact

$BSVNNeutralMedium confidence
Context

Bank7 Corp. insider Haines Douglas A sold 1,000 shares at $44.0740 on 2026-05-28, per a newly filed Form 4.

Expected impact

Limited, likely sentiment-only impact; any move should fade unless accompanied by other company-specific catalysts.

Evidence & confidence

The filing is a disclosed insider transaction with no 10b5-1 plan and a modest dollar value ($44k). Insider sales alone rarely drive sustained repricing without corroborating news.

Market effects

No clear sector read-through from a single small insider sale.

None indicated.

None indicated.

Counterpoint

The sale may be unrelated to outlook (taxes, diversification, planned liquidity needs), especially given the small size relative to typical insider holdings.

Key entities

  • Bank7 Corp.

    Subject of the Form 4 insider transaction disclosure.

  • Haines Douglas A

    Reg. Pres. of West. OK & KS who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BSVNMed

Piper Sandler raises Bank7 stock price target on strong growth

Piper Sandler raised its price target for Bank7 Corp. (BSVN) to $69.00, citing strong Q3 results with 2.24% return on assets and 16.4% return on tangible common equity. The stock is near its 52-week high, up 38% year-to-date. Piper Sandler also increased its EPS estimates for 2026 and 2027, anticipating growth from the Century Bank acquisition. Bank7 reported Q3 earnings of $1.06 per share, beating estimates, but missed on revenue.

$BSVNMed

Bank7 (BSVN) Q3 2026 Earnings Call Transcript

Bank7 (BSVN) reported Q3 2026 earnings, highlighting strong deposit growth and an upcoming merger with Century in New Mexico. The merger is expected to be neutral to their net interest margin (NIM) but will provide cheaper funding. Bank7 plans to maintain its loan growth trajectory and deploy excess liquidity methodically. Century's loan portfolio will be integrated similarly to Bank7's existing strategy.

$BSVNHighAI 8/10

Bank7 Q3 2026 slides: earnings beat forecast as Century merger nears

Bank7 Corp (BSVN) reported Q3 2026 earnings of $1.06 per share, beating estimates, with revenue at $23.37M, slightly below forecasts. Stock rose 2.02% in premarket trading. The bank saw 22.3% net income growth and announced a $137M acquisition of Century Financial, expected to close November 1, 2026, adding $1.2B in deposits. Management expects EPS accretion of over 25% from the deal.

$BSVNMed

Bank7: Q3 Earnings Presentation

Bank7 reported Q3 2026 earnings with total assets of $2.01B, net income of $10.2M, and diluted EPS of $1.06. Key metrics include a 22.3% increase in net income and a 21.8% rise in EPS. The bank announced an acquisition of Century Financial for $137M, expected to close November 1, 2026, with projected EPS accretion of 25%.